CSL Limited (ASX: CSL) Share Price and News
Price
Movement
52 Week Range
1 Year Return
() Chart and Price Data
CSL Limited (ASX: CSL) Latest News
Pfizer COVID-19 vaccine given green light for use in Australia
Mitchell Lawler | January 25, 2021 12:31pm
ASX 200 Weekly Wrap: Change in America spurs ASX 200 higher
Sebastian Bowen | January 25, 2021 8:51am
Afterpay and BrainChip were some of the most traded ASX shares last week
James Mickleboro | January 20, 2021 1:46pm
ASX 200 Weekly Wrap: ASX drops despite promises of more US stimulus
Sebastian Bowen | January 18, 2021 8:19am
Recent Stock Announcements
| Date | Heading | An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security. | Time | Pages | File Size |
|---|---|---|---|---|---|
About CSL Limited (ASX: CSL)
CSL Limited (CSL) is a global biotechnology company that develops and delivers innovative biotherapies and influenza vaccines to protect public health and help people with life-threatening medical conditions live full lives.
While the company has been in operation for more than a century, CSL shares were first listed on the ASX in 1994 within the healthcare sector – today, CSL sits as one of the largest companies on the ASX. The CSL share price has risen exponentially since first listing on the ASX and is now considered a traditional growth stock – CSL is known to lift profit, year-on-year, and invest much of it back into research and development and capital expenditure.
CSL’s operational businesses include CSL Behring and Seqirus, and the company operates predominantly in Australia, the USA, Germany, the United Kingdom and Switzerland.
Director Transactions
Data provided by Morningstar.Directors & Management
Data provided by Morningstar.Top Share Holders
Data provided by Morningstar.| Name | Shares | Capital |
|---|---|---|
| Hsbc Custody Nominees (Australia) Limited | 154,130,927 | 33.95% |
| J P Morgan Nominees Australia Pty Limited | 81,317,162 | 17.91% |
| Citicorp Nominees Pty Limited | 33,409,768 | 7.36% |
| National Nominees Limited | 12,932,543 | 2.85% |
| BNP Paribas Nominees Pty Ltd | 7,884,394 | 1.74% |
| Bnp Paribas Noms Pty Ltd | 5,625,521 | 1.24% |
| Citicorp Nominees Pty Limited I | 4,314,290 | 0.95% |
| Hsbc Custody Nominees (Australia) Limited I | 2,547,501 | 0.56% |
| Australian Foundation Investment Company Limited | 2,012,754 | 0.44% |
| Netwealth Investments Limited | 1,499,000 | 0.33% |
| Custodial Services Limited | 1,386,344 | 0.31% |
| Solium Nominees (Australia) | 1,365,798 | 0.30% |
| Argo Investments Limited | 1,113,370 | 0.25% |
| Hsbc Custody Nominees (Australia) Limited II | 866,277 | 0.19% |
| Hsbc Custody Nominees (Australia) Limited III | 857,419 | 0.19% |
| D W S Nominees Pty Ltd | 793,090 | 0.17% |
| Bnp Paribas Nominees Pty Ltd Hub24 Custodial Serv Ltd | 724,197 | 0.16% |
| Amp Life Limited | 704,273 | 0.16% |
| Mutual Trust Pty Ltd | 652,588 | 0.14% |
| Navigator Australia Ltd | 608,222 | 0.13% |
FAQ
What was CSL's float price?
CSL originally floated in 1994 at $2.30 per share. However, taking into account share buybacks the company has embarked on, the adjusted entry price is equivalent to around 76 cents. Given CSL’s current share price, original shareholders would be very pleased!
Will CSL pay a dividend in 2020?
CSL has paid twice yearly dividends every year since late 1997, a little over three years after the company’s initial listing on the ASX. Up until early 2005, CSL’s dividends were all fully franked. Since then, franking credits have been intermittent with all dividends since 2012 having been unfranked. CSL paid an interim dividend of $1.47 on 9 April 2020 and is scheduled to pay its final dividend early to mid-October.
Does CSL offer a DRP?
CSL has a dividend reinvestment plan however it has not been active since 2004. Instead, CSL periodically executes share buybacks as a way of delivering additional returns for shareholders.